about
Characterization of changes in gene expression and biochemical pathways at low levels of benzene exposureMutation analysis of hCDC4 in AML cells identifies a new intronic polymorphism.High-resolution kinetics of cytokine signaling in human CD34/CD117-positive cells in unfractionated bone marrow.High levels of CD34+CD38low/-CD123+ blasts are predictive of an adverse outcome in acute myeloid leukemia: a Groupe Ouest-Est des Leucemies Aigues et Maladies du Sang (GOELAMS) study.Dynamic single-cell network profiles in acute myelogenous leukemia are associated with patient response to standard induction therapyTranscriptional profiling of swine lung tissue after experimental infection with Actinobacillus pleuropneumoniae.The microtubule depolymerizing agent CYT997 effectively kills acute myeloid leukemia cells via activation of caspases and inhibition of PI3K/Akt/mTOR pathway proteinsEvaluation of BAALC gene expression in normal cytogenetic acute myeloid leukemia patients in north-east of Iran.Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia.Acute myeloid leukemia is characterized by Wnt pathway inhibitor promoter hypermethylation.Ubiquitin conjugase UBCH8 targets active FMS-like tyrosine kinase 3 for proteasomal degradation.High constitutive Akt2 activity in U937 promonocytes: effective reduction of Akt2 phosphorylation by the histamine H2-receptor and the β2-adrenergic receptor.Tyrosine kinase inhibition increases the cell surface localization of FLT3-ITD and enhances FLT3-directed immunotherapy of acute myeloid leukemia.Dual PI3K/mTOR inhibition shows antileukemic activity in MLL-rearranged acute myeloid leukemia.
P2860
Q28385049-75F53D22-4A07-49C5-81CA-3DDFD63CE63DQ33262849-2CEF7180-39AF-4591-8FFC-795F7E0D0961Q34924515-9F6A903A-20F0-4C6C-B44A-BF0F7237E433Q35596914-FA589E7D-B13A-49F4-9958-5568AE9FB52EQ36065836-3EBC5AE0-338B-4ED9-AE6E-1BD439042C5DQ36913786-73CC8AB7-323D-4164-8DB0-A59A4D170094Q37207284-4B462CF3-9D4A-4FDA-9DEE-79D4DCA0FA02Q37640487-55B44B7D-C714-4626-B4D4-DE30C994BD89Q37642294-BB828506-F6A0-4AC1-AAAF-0F39C1E65C64Q37723831-4E631511-7E2A-4965-9D8D-AFE648B23B89Q39699250-FB7DE66B-DB78-4BE3-B555-5755A20926C3Q46652753-10A8903E-EB7C-4131-9827-DAA97E390C66Q47818563-5AF7E799-4760-49FC-93A1-91596D2C76F2Q54315033-C40E0C04-98B2-4520-8845-A72798208400
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
The molecular pathogenesis of acute myeloid leukemia.
@ast
The molecular pathogenesis of acute myeloid leukemia.
@en
type
label
The molecular pathogenesis of acute myeloid leukemia.
@ast
The molecular pathogenesis of acute myeloid leukemia.
@en
prefLabel
The molecular pathogenesis of acute myeloid leukemia.
@ast
The molecular pathogenesis of acute myeloid leukemia.
@en
P2093
P1476
The molecular pathogenesis of acute myeloid leukemia.
@en
P2093
Björn Steffen
Hubert Serve
Joachim Schwäble
Wolfgang E Berdel
P304
P356
10.1016/J.CRITREVONC.2004.10.012
P577
2005-10-19T00:00:00Z